Roles for the mycobiome in liver disease

被引:26
作者
Zeng, Suling [1 ,2 ]
Schnabl, Bernd [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Med, MC0063,9500 Gilman Dr, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA
关键词
alcohol-associated liver disease; cirrhosis; fungi; fungi-bacterial interaction; immune response; yeast; non-alcoholic fatty liver disease; HEPATOCELLULAR-CARCINOMA; INTESTINAL PERMEABILITY; FUNGAL-INFECTIONS; CANDIDA-ALBICANS; IMMUNITY; MANAGEMENT; BACTERIAL; EXPOSURE; RATS;
D O I
10.1111/liv.15160
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver disease, a major cause of global mortality, has been associated with dysbiosis of the intestinal microbiota (bacteria, fungi, viruses, and other microbes). Studies have associated changes in gut bacteria with pathogenesis and severity of liver disease, but the contributions of the mycobiome (the fungal populations of the gut) to health and disease have not been well studied. We review recent findings of alterations in the composition of the mycobiota in patients with liver disease and discuss the mechanisms by which these might affect pathogenesis and disease progression. Strategies to manipulate the gut mycobiota might be developed to treat or prevent liver disease.
引用
收藏
页码:729 / 741
页数:13
相关论文
共 72 条
[1]   Farnesol attenuates oxidative stress and liver injury and modulates fatty acid synthase and acetyl-CoA carboxylase in high cholesterol-fed rats [J].
Abukhalil, Mohammad H. ;
Hussein, Omnia E. ;
Bin-Jumah, May ;
Saghir, Sultan A. M. ;
Germoush, Mousa O. ;
Elgebaly, Hassan A. ;
Mosa, Nermeen M. ;
Hamad, Ismail ;
Qarmush, Moath M. ;
Hassanein, Emad M. ;
Kamel, Emadeldin M. ;
Hernandez-Bautista, Rene ;
Mahmoud, Ayman M. .
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2020, 27 (24) :30118-30132
[2]   Quorum sensing in fungi - a review [J].
Albuquerque, Patricia ;
Casadevall, Arturo .
MEDICAL MYCOLOGY, 2012, 50 (04) :337-345
[3]   Fungal infections in patients with cirrhosis [J].
Alexopoulou, Alexandra ;
Vasilieva, Larisa ;
Agiasotelli, Danai ;
Dourakis, Spyros P. .
JOURNAL OF HEPATOLOGY, 2015, 63 (04) :1043-1045
[4]  
Alqahtani S.A., 2020, Hepatoma Res, V6, P10, DOI [10.20517/2394-5079.2020.49, DOI 10.20517/2394-5079.2020.49]
[5]   Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg [J].
Arab, Juan P. ;
Martin-Mateos, Rosa M. ;
Shah, Vijay H. .
HEPATOLOGY INTERNATIONAL, 2018, 12 :S24-S33
[6]   Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders [J].
Aron-Wisnewsky, Judith ;
Vigliotti, Chloe ;
Witjes, Julia ;
Le, Phuong ;
Holleboom, Adriaan G. ;
Verheij, Joanne ;
Nieuwdorp, Max ;
Clement, Karine .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) :279-297
[7]   Burden of liver diseases in the world [J].
Asrani, Sumeet K. ;
Devarbhavi, Harshad ;
Eaton, John ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :151-171
[8]   Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans [J].
Bacher, Petra ;
Hohnstein, Thordis ;
Beerbaum, Eva ;
Roecker, Marie ;
Blango, Matthew G. ;
Kaufmann, Svenja ;
Roehmel, Jobst ;
Eschenhagen, Patience ;
Grehn, Claudia ;
Seidel, Kathrin ;
Rickerts, Volker ;
Lozza, Laura ;
Stervbo, Ulrik ;
Nienen, Mikalai ;
Babel, Nina ;
Milleck, Julia ;
Assenmacher, Mario ;
Cornely, Oliver A. ;
Ziegler, Maren ;
Wisplinghoff, Hilmar ;
Heine, Guido ;
Worm, Margitta ;
Siegmund, Britta ;
Maul, Jochen ;
Creutz, Petra ;
Tabeling, Christoph ;
Ruwwe-Gloesenkamp, Christoph ;
Sander, Leif E. ;
Knosalla, Christoph ;
Brunke, Sascha ;
Hube, Bernhard ;
Kniemeyer, Olaf ;
Brakhage, Axel A. ;
Schwarz, Carsten ;
Scheffold, Alexander .
CELL, 2019, 176 (06) :1340-+
[9]   Fungal dysbiosis in cirrhosis [J].
Bajaj, Jasmohan S. ;
Liu, Eric J. ;
Kheradman, Raffi ;
Fagan, Andrew ;
Heuman, Douglas M. ;
White, Melanie ;
Gavis, Edith A. ;
Hylemon, Phillip ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
GUT, 2018, 67 (06) :1146-1154
[10]  
Centers for Disease Control and Prevention, 2021, CAUS DEATH 1999 2019